J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

The Aventus thrombectomy system uses technology that tells the operator if the device’s tip is in contact with blood, a clot ...